CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $37.16M, above the global median of $16.24M
- FinancialsAltman Z-Score 2.14: grey zone
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
393.58MUSDvs all stocks (USD)
Trailing P/E
90.48xvs Health Information Services peers
Revenue (TTM)
345.90MUSDvs all stocks (USD)
Profit Margin
1.27%vs Health Information Services peers
Beta
1.29xvs all stocks
52-Week Change
17.14%vs all stocks
Market Capitalization
393.58MUSDvs all stocks (USD)
Enterprise Value
521.53MUSDvs all stocks (USD)
Trailing P/E
90.48xvs Health Information Services peers
Forward P/E
8.86xvs Health Information Services peers
Price to Sales (TTM)
1.14xvs Health Information Services peers
Price to Book (MRQ)
2.16xvs Health Information Services peers
Enterprise to Revenue
1.51xvs Health Information Services peers
Enterprise to EBITDA
15.42xvs Health Information Services peers
Gross Margin
55.55%vs Health Information Services peers
Profit Margin
1.27%vs Health Information Services peers
Operating Margin
4.70%vs Health Information Services peers
Return on Assets (TTM)
3.24%vs Health Information Services peers
Return on Equity (TTM)
2.54%vs Health Information Services peers
Revenue (TTM)
345.90MUSDvs all stocks (USD)
Revenue per Share (TTM)
23.80USDUpdated Jul 19, 2026Quarterly Revenue Growth
-1.10%vs Health Information Services peers
Gross Profit (TTM)
184.09MUSDvs all stocks (USD)
EBITDA (TTM)
37.83MUSDvs all stocks (USD)
Net Income (TTM)
4.26MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
10.20%vs Health Information Services peers
Operating Cash Flow (TTM)
46.66MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
37.16MUSDvs all stocks (USD)
5-Year Average Dividend Yield
2.46%vs all stocks
Payout Ratio
0.00%vs Health Information Services peers
Revenue
346.84MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
162.97MUSDFY2025 · Dec 31, 2025Gross Profit
183.86MUSDFY2025 · Dec 31, 2025Operating Income
20.83MUSDvs all stocks (USD)
Pre-tax Income
3.87MUSDFY2025 · Dec 31, 2025Income Tax Expense
-485.00KUSDFY2025 · Dec 31, 2025Net Income
4.35MUSDFY2025 · Dec 31, 2025EBIT
16.18MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
42.46MUSDFY2025 · Dec 31, 2025Research & Development
32.56MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
104.20MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
12.32MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.2900USDFY2025 · Dec 31, 2025EPS (Diluted)
0.2900USDFY2025 · Dec 31, 2025Basic Shares Outstanding
14.49MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
14.49MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
4.35MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
145.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
36.79MUSDFY2025 · Dec 31, 2025Free Cash Flow
35.77MUSDDerived from operating cash flow minus capital expenditure. This filing charges 26.28M of depreciation against 1.02M of capital expenditure, and its own free-cash-flow line reads 19.84M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
24.85MUSDFY2025 · Dec 31, 2025Income Tax Paid
6.04MUSDFY2025 · Dec 31, 2025Interest Paid
14.12MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
4.35MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
26.28MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
716.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
8.66MUSDFY2025 · Dec 31, 2025Other Non-cash Items
6.62MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-3.06MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
4.96MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.74MUSDFY2025 · Dec 31, 2025Capital Expenditures
-1.02MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-15.81MUSDFY2025 · Dec 31, 2025Net Acquisitions
2.10MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
1.08MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
182.87MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-189.03MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-1.95MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.60MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-9.71MUSDFY2025 · Dec 31, 2025Shares Outstanding
14.91MSharesUpdated Jul 19, 2026Float Shares
9.38MSharesUpdated Jul 19, 2026Shares Short
548.56KSharesUpdated Jul 19, 2026Short Ratio
1.94daysvs all stocks
Short % of Shares Outstanding
4.13%vs all stocks
% Held by Insiders
15.95%vs all stocks
% Held by Institutions
67.75%vs all stocks
Total Cash (MRQ)
35.42MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.39USDUpdated Jul 19, 2026Total Debt (MRQ)
168.46MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.9427xvs Health Information Services peers
Current Ratio (MRQ)
1.78xvs Health Information Services peers
Book Value per Share (MRQ)
12.14USDUpdated Jul 19, 2026Total Assets
402.53MUSDvs all stocks (USD)
Total Current Assets
104.64MUSDFY2025 · Dec 31, 2025Total Liabilities
224.57MUSDFY2025 · Dec 31, 2025Total Non-current Assets
297.88MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
166.61MUSDFY2025 · Dec 31, 2025Total Current Liabilities
57.96MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
24.85MUSDFY2025 · Dec 31, 2025Accounts Receivable
54.97MUSDFY2025 · Dec 31, 2025Inventory
623.00KUSDFY2025 · Dec 31, 2025Accounts Payable
19.55MUSDFY2025 · Dec 31, 2025Short-term Debt
4.16MUSDFY2025 · Dec 31, 2025Deferred Revenue
9.21MUSDFY2025 · Dec 31, 2025Long-term Debt
162.59MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
1.44MUSDFY2025 · Dec 31, 2025Common Stock (Book)
15.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-12.22MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
177.96MUSDvs all stocks (USD)
Treasury Stock
19.43MUSDFY2025 · Dec 31, 202552-Week Low
13.88USDUpdated Jul 19, 202652-Week High
26.51USDUpdated Jul 19, 202652-Week Change
17.14%vs all stocks
Beta
1.29xvs all stocks
50-Day MA
26.04USDUpdated Jul 19, 2026200-Day MA
21.76USDUpdated Jul 19, 2026Avg 10-Day Volume
241.18KSharesUpdated Jul 19, 2026Avg 30-Day Volume
264.03KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.2900USDUpdated Jul 19, 2026Other Income / Expense
-4.65MUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Cash-Backed Earnings Configuration
More cash comes in than it reports as profit, little goes back out on equipment, and much of the gap is depreciation.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.56Profit Margin: 0.01
Financial Health
Altman Z-Score 2.14: grey zoneSignificant
Altman Z-Score: 2.14
High earnings qualityNotable
Earnings Quality Score: 0.99
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Levered free cash flow is $37.16M, above the global median of $16.24MNotable
Levered free cash flow (USD): 37,162,248Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Yeahka Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Ribbon Communications Inc.
Tier 1FlowRecurring-Revenue Lock-InProductionRule
International Money Express Inc.
Tier 1FlowRecurring-Revenue Lock-InRiskInterface
Bright Oceans Inter-Telecom Corp.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Allot Ltd.
Tier 1FlowRecurring-Revenue Lock-InProductionRule
Lesaka Technologies, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
63 Moons Technologies Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Paysafe Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
NHN KCP Corp.
Tier 1FlowRecurring-Revenue Lock-InRiskInterface
Rimini Street Inc.
Tier 1FlowRecurring-Revenue Lock-InSenseMakingInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Sunshine Guojian Pharmaceutical Co., Ltd.
3 interpretationsFCF Ratios ElevatedUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown
China Silver Group Limited
3 interpretationsFCF Ratios ElevatedUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown
Arko Petroleum Corp.
3 interpretationsDecline With Range Expansion And DrawdownCash-Backed Earnings ConfigurationDepreciation-Heavy Reported Profit